GdX/UBL4A specifically stabilizes the TC45/STAT3 association and promotes dephosphorylation of STAT3 to repress tumorigenesis

Molecular Cell

Volumn 53, Issue 5, 2014, Pages 752-765

  Wang, Yangmeng ^a   Ning, Hongxiu ^a,b   Ren, Fangli ^a   Zhang, Yuanjiang ^a   Rong, Yu ^a   Wang, Yinyin ^a   Su, Fuqin ^a   Cai, Chenguang ^a   Jin, Zhe ^a   Li, Zhiyong ^a   Gong, Xinqi ^a   Zhai, Yonggong ^c   Wang, Dianjun ^d   Jia, Baoqing ^d   Qiu, Ying ^a   Tomita, Yasuhiko ^e   Sung, JosephJ Y ^f   Yu, Jun ^f   Irwin, DavidM ^g   Yang, Xiao ^h   Fu, Xinyuan ⁱ   Chin, Y Eugene ^j   Chang, Zhijie ^a   more..

^a Tsinghua University   (China)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c BEIJING NORMAL UNIVERSITY   (China)

^d CHINESE PLA GENERAL HOSPITAL   (China)

^e OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

^f CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^g UNIVERSITY OF TORONTO   (Canada)

^h BEIJING INSTITUTE OF BIOTECHNOLOGY   (China)

ⁱ NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^j SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

more..

Author keywords

[No Author keywords available]

Indexed keywords

DNA; INTERLEUKIN 6; ISOPROTEIN; STAT3 PROTEIN; TC45 PROTEIN; UNCLASSIFIED DRUG; GDX PROTEIN; PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; CELLULAR DISTRIBUTION; COLON CARCINOGENESIS; COLORECTAL CARCINOGENESIS; COMPLEX FORMATION; CONTROLLED STUDY; CYTOKINE RESPONSE; DEPHOSPHORYLATION; DNA BINDING; GDX GENE; GEL MOBILITY SHIFT ASSAY; GENE DELETION; GENETIC ASSOCIATION; GENETIC STABILITY; HOUSEKEEPING GENE; MOUSE; NONHUMAN; PROTEIN PROTEIN INTERACTION; ANIMAL CELL; CARCINOGENESIS; CELL NUCLEUS; CELL TRANSFORMATION; COLITIS; COLORECTAL CANCER; CONCENTRATION (PARAMETERS); METASTASIS INHIBITION; PROTEIN DEPHOSPHORYLATION; PROTEIN STABILITY; TRANSCRIPTION TERMINATION;

ANIMALS; CARCINOGENESIS; CELL TRANSFORMATION, NEOPLASTIC; CERCOPITHECUS AETHIOPS; COS CELLS; CYTOKINES; FIBROBLASTS; GENE DELETION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MCF-7 CELLS; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED BALB C; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 2; STAT3 TRANSCRIPTION FACTOR; UBIQUITINS;

EID: 84896699923     PISSN: 10972765     EISSN: 10974164     Source Type: Journal    
DOI: 10.1016/j.molcel.2014.01.020     Document Type: Article

References (44)

1. Aoki N., Matsuda T. A nuclear protein tyrosine phosphatase TC-PTP is a potential negative regulator of the PRL-mediated signaling pathway: dephosphorylation and deactivation of signal transducer and activator of transcription 5a and 5b by TC-PTP in nucleus. Mol. Endocrinol. 2002, 16:58-69.
2. Bard-Chapeau E.A., Li S., Ding J., Zhang S.S., Zhu H.H., Princen F., Fang D.D., Han T., Bailly-Maitre B., Poli V., et al. Ptpn11/Shp2 acts as a tumor suppressor in hepatocellular carcinogenesis. Cancer Cell 2011, 19:629-639.
3. Bowman T., Broome M.A., Sinibaldi D., Wharton W., Pledger W.J., Sedivy J.M., Irby R., Yeatman T., Courtneidge S.A., Jove R. Stat3-mediated Myc expression is required for Src transformation and PDGF-induced mitogenesis. Proc. Natl. Acad. Sci. USA 2001, 98:7319-7324.
4. Brantley E.C., Nabors L.B., Gillespie G.Y., Choi Y.H., Palmer C.A., Harrison K., Roarty K., Benveniste E.N. Loss of protein inhibitors of activated STAT-3 expression in glioblastoma multiforme tumors: implications for STAT-3 activation and gene expression. Clin. Cancer Res. 2008, 14:4694-4704.
5. Bromberg J. Stat proteins and oncogenesis. J.Clin. Invest. 2002, 109:1139-1142.
6. Bromberg J.F., Wrzeszczynska M.H., Devgan G., Zhao Y., Pestell R.G., Albanese C., Darnell J.E. Stat3 as an oncogene. Cell 1999, 98:295-303.
7. Catlett-Falcone R., Landowski T.H., Oshiro M.M., Turkson J., Levitzki A., Savino R., Ciliberto G., Moscinski L., Fernández-Luna J.L., Nuñez G., et al. Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells. Immunity 1999, 10:105-115.
8. Epling-Burnette P.K., Liu J.H., Catlett-Falcone R., Turkson J., Oshiro M., Kothapalli R., Li Y., Wang J.M., Yang-Yen H.F., Karras J., et al. Inhibition of STAT3 signaling leads to apoptosis of leukemic large granular lymphocytes and decreased Mcl-1 expression. J.Clin. Invest. 2001, 107:351-362.
9. Franken N.A., Rodermond H.M., Stap J., Haveman J., van Bree C. Clonogenic assay of cells invitro. Nat. Protoc. 2006, 1:2315-2319.
10. Galm O., Yoshikawa H., Esteller M., Osieka R., Herman J.G. SOCS-1, a negative regulator of cytokine signaling, is frequently silenced by methylation in multiple myeloma. Blood 2003, 101:2784-2788.
11. Gao S.P., Mark K.G., Leslie K., Pao W., Motoi N., Gerald W.L., Travis W.D., Bornmann W., Veach D., Clarkson B., Bromberg J.F. Mutations in the EGFR kinase domain mediate STAT3 activation via IL-6 production in human lung adenocarcinomas. J.Clin. Invest. 2007, 117:3846-3856.
12. Garcia R., Bowman T.L., Niu G., Yu H., Minton S., Muro-Cacho C.A., Cox C.E., Falcone R., Fairclough R., Parsons S., et al. Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells. Oncogene 2001, 20:2499-2513.
13. Grandis J.R., Drenning S.D., Zeng Q., Watkins S.C., Melhem M.F., Endo S., Johnson D.E., Huang L., He Y., Kim J.D. Constitutive activation of Stat3 signaling abrogates apoptosis in squamous cell carcinogenesis invivo. Proc. Natl. Acad. Sci. USA 2000, 97:4227-4232.
14. Grivennikov S., Karin E., Terzic J., Mucida D., Yu G.Y., Vallabhapurapu S., Scheller J., Rose-John S., Cheroutre H., Eckmann L., Karin M. IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer. Cancer Cell 2009, 15:103-113.
15. Han Y., Amin H.M., Franko B., Frantz C., Shi X., Lai R. Loss of SHP1 enhances JAK3/STAT3 signaling and decreases proteosome degradation of JAK3 and NPM-ALK in ALK+ anaplastic large-cell lymphoma. Blood 2006, 108:2796-2803.
16. Hart J.R., Liao L., Yates J.R., Vogt P.K. Essential role of Stat3 in PI3K-induced oncogenic transformation. Proc. Natl. Acad. Sci. USA 2011, 108:13247-13252.
17. He G., Karin M. NF-κB and STAT3 - key players in liver inflammation and cancer. Cell Res. 2011, 21:159-168.
18. Hirano T., Ishihara K., Hibi M. Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors. Oncogene 2000, 19:2548-2556.
19. Levy D.E., Darnell J.E. Stats: transcriptional control and biological impact. Nat. Rev. Mol. Cell Biol. 2002, 3:651-662.
20. Liang J., Nagahashi M., Kim E.Y., Harikumar K.B., Yamada A., Huang W.C., Hait N.C., Allegood J.C., Price M.M., Avni D., et al. Sphingosine-1-phosphate links persistent STAT3 activation, chronic intestinal inflammation, and development of colitis-associated cancer. Cancer Cell 2013, 23:107-120.
21. Lu D., Wu Y., Wang Y., Ren F., Wang D., Su F., Zhang Y., Yang X., Jin G., Hao X., et al. CREPT accelerates tumorigenesis by regulating the transcription of cell-cycle-related genes. Cancer Cell 2012, 21:92-104.
22. Mariappan M., Li X., Stefanovic S., Sharma A., Mateja A., Keenan R.J., Hegde R.S. A ribosome-associating factor chaperones tail-anchored membrane proteins. Nature 2010, 466:1120-1124.
23. Nakajima K., Matsuda T., Fujitani Y., Kojima H., Yamanaka Y., Nakae K., Takeda T., Hirano T. Signal transduction through IL-6 receptor: involvement of multiple protein kinases, stat factors, and a novel H7-sensitive pathway. Ann. N Y Acad. Sci. 1995, 762:55-70.
24. Neufert C., Becker C., Neurath M.F. An inducible mouse model of colon carcinogenesis for the analysis of sporadic and inflammation-driven tumor progression. Nat. Protoc. 2007, 2:1998-2004.
25. Niu G., Wright K.L., Huang M., Song L., Haura E., Turkson J., Zhang S., Wang T., Sinibaldi D., Coppola D., et al. Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis. Oncogene 2002, 21:2000-2008.
26. Ostman A., Hellberg C., Böhmer F.D. Protein-tyrosine phosphatases and cancer. Nat. Rev. Cancer 2006, 6:307-320.
27. Prenzel N., Fischer O.M., Streit S., Hart S., Ullrich A. The epidermal growth factor receptor family as a central element for cellular signal transduction and diversification. Endocr. Relat. Cancer 2001, 8:11-31.
28. Ren F., Su F., Ning H., Wang Y., Geng Y., Feng Y., Wang Y., Zhang Y., Jin Z., Li Y., et al. SIPAR negatively regulates STAT3 signaling and inhibits progression of melanoma. Cell. Signal. 2013, 25:2272-2280.
29. Rong Y., Cheng L., Ning H., Zou J., Zhang Y., Xu F., Liu L., Chang Z., Fu X.Y. Wilms' tumor 1 and signal transducers and activators of transcription 3 synergistically promote cell proliferation: a possible mechanism in sporadic Wilms' tumor. Cancer Res. 2006, 66:8049-8057.
30. Simoncic P.D., Lee-Loy A., Barber D.L., Tremblay M.L., McGlade C.J. The Tcell protein tyrosine phosphatase is a negative regulator of janus family kinases 1 and 3. Curr. Biol. 2002, 12:446-453.
31. Song J.I., Grandis J.R. STAT signaling in head and neck cancer. Oncogene 2000, 19:2489-2495.
32. Stephanou A., Latchman D.S. Opposing actions of STAT-1 and STAT-3. Growth Factors 2005, 23:177-182.
33. Su F., Ren F., Rong Y., Wang Y., Geng Y., Wang Y., Feng M., Ju Y., Li Y., Zhao Z.J., et al. Protein tyrosine phosphatase Meg2 dephosphorylates signal transducer and activator of transcription 3 and suppresses tumor growth in breast cancer. Breast Cancer Res. 2012, 14:R38.
34. ten Hoeve J., de Jesus Ibarra-Sanchez M., Fu Y., Zhu W., Tremblay M., David M., Shuai K. Identification of a nuclear Stat1 protein tyrosine phosphatase. Mol. Cell. Biol. 2002, 22:5662-5668.
35. Toniolo D., Persico M., Alcalay M. A "housekeeping" gene on the X chromosome encodes a protein similar to ubiquitin. Proc. Natl. Acad. Sci. USA 1988, 85:851-855.
36. Turkson J., Bowman T., Garcia R., Caldenhoven E., De Groot R.P., Jove R. Stat3 activation by Src induces specific gene regulation and is required for cell transformation. Mol. Cell. Biol. 1998, 18:2545-2552.
37. Wang Q., Liu Y., Soetandyo N., Baek K., Hegde R., Ye Y. A ubiquitin ligase-associated chaperone holdase maintains polypeptides in soluble states for proteasome degradation. Mol. Cell 2011, 42:758-770.
38. Wang Y., Wang D., Ren F., Zhang Y., Lin F., Hou N., Cheng X., Zhang P., Wang Y., Jia B., et al. Generation of mice with conditional null allele for GdX/Ubl4A. Genesis 2012, 50:534-542.
39. Wen Z., Zhong Z., Darnell J.E. Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation. Cell 1995, 82:241-250.
40. Yamamoto T., Sekine Y., Kashima K., Kubota A., Sato N., Aoki N., Matsuda T. The nuclear isoform of protein-tyrosine phosphatase TC-PTP regulates interleukin-6-mediated signaling pathway through STAT3 dephosphorylation. Biochem. Biophys. Res. Commun. 2002, 297:811-817.
41. Yoshikawa H., Matsubara K., Qian G.S., Jackson P., Groopman J.D., Manning J.E., Harris C.C., Herman J.G. SOCS-1, a negative regulator of the JAK/STAT pathway, is silenced by methylation in human hepatocellular carcinoma and shows growth-suppression activity. Nat. Genet. 2001, 28:29-35.
42. Zhang Q., Raghunath P.N., Xue L., Majewski M., Carpentieri D.F., Odum N., Morris S., Skorski T., Wasik M.A. Multilevel dysregulation of STAT3 activation in anaplastic lymphoma kinase-positive T/null-cell lymphoma. J.Immunol. 2002, 168:466-474.
43. Zhang X., Guo A., Yu J., Possemato A., Chen Y., Zheng W., Polakiewicz R.D., Kinzler K.W., Vogelstein B., Velculescu V.E., Wang Z.J. Identification of STAT3 as a substrate of receptor protein tyrosine phosphatase T. Proc. Natl. Acad. Sci. USA 2007, 104:4060-4064.
44. Zhong Z., Wen Z., Darnell J.E. Stat3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6. Science 1994, 264:95-98.